Article Details

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric ...

Retrieved on: 2022-01-11 05:05:44

Tags for this article:

Click the tags to see associated articles and topics

Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric .... View article details on hiswai:

Excerpt

(NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up